With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...

to the US FDA for the investigational agent vortioxetine. Vortioxetine (Lu AA21004) is under investigation as an antidepressant for the treatment of major depressive disorder (MDD) in adult patients.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Axsome Therapeutics (AXSM) stock rallied 15% on news the company has settled patent litigation with Teva (TEVA) over a ...

Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

Hydroxyzine and Benadryl are both sedating antihistamines. They share many similarities but have different approved uses, ...

Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...

About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

Cantor Fitzgerald analyst Charles Duncan initiated coverage of GH Research (GHRS) with an Overweight rating and no price target GH Research is ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew ...